In the conclusion of our reporting from the Festival of Biologics USA meeting last week, we covered present effects on the upcoming biosimilar pipeline as well as the area of biosimilar delivery device testing and regulation. DIFFICULT DECISIONS AHEAD ON THE BIOSIMILAR PIPELINE Michael Sarshad, Managing Director, Syneos Health Consulting, believes that there are many … Continue reading Biosimilars at the Festival of Biologics: Part 2: Biosimilar Pipeline and Delivery Devices